Skip to content

Adjuvant Oxytocin for Preinduction Ripening With a Foley catheter--a Clinical Trial

A Prospective, Randomized Trial of Transcervical Foley Catheter With or Without Oxytocin for Preinduction Cervical Ripening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00468520
Enrollment
200
Registered
2007-05-02
Start date
2003-11-30
Completion date
2005-10-31
Last updated
2011-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Ripening, Induced Labor, Pregnancy

Keywords

induction of labor, cervical ripening, Foley catheter, oxytocin

Brief summary

The transcervical Foley catheter (TFC) is a proven and effective mode of cervical ripening. It is common practice to use TFC with simultaneous low-dose oxytocin under the assumption that the combination results in a more successful labor induction. Scientific validation of this practice is lacking. We seek to determine if the addition of oxytocin to TFC improves induction success.

Detailed description

This is a prospective, randomized trial that aims to enroll 200 singleton pregnancies presenting for preinduction ripening. Patients will be randomized to receive either TFC alone (control) or TFC plus low-dose oxytocin (treatment). Providers will not blinded to use of oxytocin and labor was managed according to routine obstetric protocols. This study is powered to detect a 20% difference in the proportion of patients delivered within 24 hours, the primary outcome. Secondary outcomes are related to vaginal delivery rate, duration of induction, complications, and pain management.

Interventions

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* singleton gestation * presenting for induction as determined by their primary obstetrical provider * with fetuses in cephalic presentation * gestational age greater than 23 weeks

Exclusion criteria

* any condition precluding vaginal delivery * estimated fetal weight \>4500 grams * a previous attempt at ripening or induction during the pregnancy * clinically significant cervical or vaginal infection * chorioamnionitis * HIV * hepatitis B or C * unexplained vaginal bleeding * low-lying placenta * abnormal cervical anatomy or cervical cerclage * latex allergy

Design outcomes

Primary

MeasureTime frame
Delivery rate (proportion)Within 24 hours

Secondary

MeasureTime frame
vaginal delivery ratewithin 24 hours
use of anesthesia/analgesiaduring induction and labor
overall complication rate (composite)
duration of induction and labor

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026